TY - JOUR
T1 - A novel retroauricular fixed port for hemodialysis
T2 - surgical procedure and preliminary results of the clinical investigation
AU - Caversaccio, Marco
AU - Wimmer, Wilhelm
AU - Widmer, Matthias
AU - Bachtler, Matthias
AU - Kalicki, Robert
AU - Uehlinger, Dominik
AU - Arnold, Andreas
N1 - Publisher Copyright:
© 2019, © 2019 Acta Oto-Laryngologica AB (Ltd).
PY - 2019/2/1
Y1 - 2019/2/1
N2 - Background: Inspired by bone conduction implants, which have a low infection rate, a bone-anchored port (BAP) system for hemodialysis was designed. Objectives: To demonstrate the surgical procedure for the BAP and to present preliminary results of the clinical investigation. Materials and Methods: Patients with end-stage renal disease and contraindications for an arteriovenous forearm fistula were recruited for BAP implantation. A workflow specifically developed for implantation was followed. Postoperative evolution, the dialysis procedure, the functionality of the implant, and signs of infection were monitored. Results: So far, five patients have been implanted with the BAP system. Hemodialysis with the BAP was unproblematic in all five patients, on average starting from the 9th day after implantation (range 2 to 15 days). Up to now, 1789 cumulative patient days (average 355 days, range 154 to 448 days) have been recorded. One patient died 14 months after implantation, from a cardiac arrest unrelated to the system. Dialysis was painless, and no catheter-related infections have occurred. Conclusion: BAP implantation can be safely performed but requires an interdisciplinary team. No infections related to the device have occurred. Significance: The presented system is a promising addition to the choices of vascular accesses for hemodialysis patients.
AB - Background: Inspired by bone conduction implants, which have a low infection rate, a bone-anchored port (BAP) system for hemodialysis was designed. Objectives: To demonstrate the surgical procedure for the BAP and to present preliminary results of the clinical investigation. Materials and Methods: Patients with end-stage renal disease and contraindications for an arteriovenous forearm fistula were recruited for BAP implantation. A workflow specifically developed for implantation was followed. Postoperative evolution, the dialysis procedure, the functionality of the implant, and signs of infection were monitored. Results: So far, five patients have been implanted with the BAP system. Hemodialysis with the BAP was unproblematic in all five patients, on average starting from the 9th day after implantation (range 2 to 15 days). Up to now, 1789 cumulative patient days (average 355 days, range 154 to 448 days) have been recorded. One patient died 14 months after implantation, from a cardiac arrest unrelated to the system. Dialysis was painless, and no catheter-related infections have occurred. Conclusion: BAP implantation can be safely performed but requires an interdisciplinary team. No infections related to the device have occurred. Significance: The presented system is a promising addition to the choices of vascular accesses for hemodialysis patients.
KW - Bone-anchored port
KW - chronic renal failure
KW - hemodialysis
KW - implant surgery
UR - http://www.scopus.com/inward/record.url?scp=85061015686&partnerID=8YFLogxK
U2 - 10.1080/00016489.2018.1562217
DO - 10.1080/00016489.2018.1562217
M3 - Article
C2 - 30714444
AN - SCOPUS:85061015686
SN - 0001-6489
VL - 139
SP - 129
EP - 134
JO - Acta Oto-Laryngologica
JF - Acta Oto-Laryngologica
IS - 2
ER -